Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

Roche announced it developed a Research Use Only (RUO) molecular PCR test via subsidiary TIB MOLBIOL within six days to detect the rare Ebola Bundibugyo virus. The test supports outbreak response efforts in Central and East Africa following WHO's declaration of a Public Health Emergency of International Concern on May 17, 2026. Roche is working with public health laboratories and authorities in affected regions to deploy the testing capability.